Lemborexant
DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies ( 14.1 )] .
United States
$331
per month
India
$15
per month
You save
−95%save $316/mo · 95% cheaper
57.9K US scripts/yr$18.3M potential annual savings$19.2M US spend/yr
Drag to rotate · 3D structureC22H20F2N4O2
SMILES: CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C
Compare the price
US price$331per month
India price$15per month
You save$31695% less
Based on 30 units per month. US $11.03 vs India $0.50 per unit.
Total over 1 periodSave $316$331 → $15
The bigger picture
Lemborexant is filled about 57.9K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$19.2M
If sourced from India
$871.8K
Potential annual savings
$18.3M
−95%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.